Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-03-15FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2007-03-15Clinical Trial Update: Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety
The update indicates the Rhapsody Registry trial in patients with depression and anxiety has completed; pain is also listed among the condit…
-
FDA approval · 2007-03-07FDA Approved: PAROXETINE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for paroxetine hydrochloride tablets (generic paroxetine). This approval prov…
-
CLINICAL_TRIALS research · 2007-03-02Clinical Trial Update: Morbidity and Mortality Among Dialysis Patients After Treatment for Depression
This clinical trial update investigates morbidity and mortality among dialysis patients after treatment for depression, sponsored by the Por…
-
CLINICAL_TRIALS research · 2007-03-02Clinical Trial Update: Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder [Phase 4]
A Phase 4 clinical trial update examining how escitalopram affects sleep architecture in patients with major depressive disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Women's Use of Alternative Medicine: A Multiethnic Study
This update reports the completion of a multiethnic clinical trial on women's use of alternative medicine, sponsored by the NCCIH. It addres…
-
FDA approval · 2007-02-09FDA Approved: FLUOXETINE — Original Application (Lannett Company, Inc.)
FDA approved the original application for a generic fluoxetine hydrochloride product from Lannett Company, Inc.
-
CLINICAL_TRIALS research · 2007-02-09Clinical Trial Update: Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors [Phase 1]
Phase 1 clinical trial focused on screening for mental health concerns among at-risk community-dwelling Chinese seniors, with conditions inc…
-
FDA approval · 2007-02-06FDA Approved: PHENELZINE SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for phenelzine sulfate submitted by Mylan Pharmaceuticals Inc., indicating regulatory approval o…
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' sertraline hydrochloride as a generic drug via an Original ANDA approval.
-
CLINICAL_TRIALS trial_result · 2007-02-06Clinical Trial Update: Treatment of Depression in the Elderly [Phase 4]
A Phase 4 trial evaluating treatment of depression in the elderly was terminated.
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA) for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, a generic version of sert…
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic sertraline hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2007-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat maj…
-
FDA approval · 2007-01-29FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for Wellbutrin SR (bupropion hydrochloride) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain [Phase 3]
Phase 3 randomized, double-blind trial evaluating duloxetine in outpatients with major depressive disorder and concomitant pain; the study h…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials [Phase 3]
An open-label Phase 3 extension study of duloxetine in patients with major depressive disorder who completed prior duloxetine trials, focusi…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response [Phase 4]
A Phase 4 bipolar depression treatment response study sponsored by Eli Lilly and Company has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder [Phase 4]
Phase 4 trial comparing tolerability and efficacy of different duloxetine doses in adults with major depressive disorder.
-
FDA approval · 2007-01-25FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine filed by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2007-01-25Clinical Trial Update: Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study [Phase 4]
An 8-week, open-label Phase 4 trial evaluating the safety and efficacy of reboxetine for depression in children and adolescents.
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: Galantamine Augmentation of Escitalopram for Treatment of Depression [Phase 4]
Phase 4 trial evaluating galantamine augmentation of escitalopram for depression was terminated. The update does not provide results.
-
CLINICAL_TRIALS trial_result · 2007-01-04Clinical Trial Update: Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. [Phase 3]
A Phase 3 trial evaluating Triiodothyronine (T3) supplementation for major depressive disorder and bipolar disorder has been completed.
-
FDA approval · 2006-12-15FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved an original ANDA for Bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, providing a generic version of the an…
-
CLINICAL_TRIALS trial_result · 2006-12-05Clinical Trial Update: Expanding Rural Access: Distance Delivery of Support [Phase 2]
Phase 2 clinical trial update on expanding rural access through distance-delivery support; the study has completed.